September 28, 2015
1 min read
Save

Cataract surgery may improve visual acuity in wet AMD patients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Cataract surgery may help improve visual acuity in wet age-related macular degeneration patients who receive anti-VEGF injections, according to a study.

The retrospective cohort study included 77 consecutive wet AMD patients. Forty eyes underwent cataract surgery at the midpoint of the 1-year study, and 42 eyes did not undergo cataract surgery during the study window.

Three months before the midpoint, best corrected visual acuity was 20/89 in both groups. Three months after the midpoint, BCVA improved to 20/53 in the surgical group and 20/69 in the non-surgical group. The between-group change was statistically significant.

There was no difference in the number of injections before and after surgery in the surgical group. The number of injections decreased from 3.00 ± 1.45 injections before the midpoint to 2.57 ± 1.45 injections after the midpoint in the non-surgical group, with the difference approaching statistical significance.

There was no significant difference in initial central retinal thickness between the groups. Surgical eyes had a significantly greater final central retinal thickness of 265.4 ± 98.4 µm compared with 216.4 ± 58.3 µm in non-surgical eyes.

Thirteen surgical eyes had significantly more new or worse cysts after the midpoint compared with nine eyes in the non-surgical group.

“Cataract surgery leads to vision improvement and does not appear to contribute to worsening of wet AMD. However, anatomic changes based on OCT analysis suggest a subclinical susceptibility to postoperative cystoid macular edema or exacerbation of choroidal neovascularization,” the study authors said. – by Kristie L. Kahl

Disclosure: The authors report no relevant financial disclosures.